Zhao X, He L
Turk J Med Sci. 2024; 53(5):1367-1378.
PMID: 38813026
PMC: 10763780.
DOI: 10.55730/1300-0144.5703.
Lima F, Fernandes F, Almeida D, Carvalho A, Almeida V, Cavalcante G
Asian Pac J Cancer Prev. 2024; 25(4):1195-1203.
PMID: 38679978
PMC: 11162731.
DOI: 10.31557/APJCP.2024.25.4.1195.
Li M, Pang X, Xu H, Xiao L
Mol Biotechnol. 2024; 67(1):304-316.
PMID: 38372878
DOI: 10.1007/s12033-024-01054-4.
Yang Q, Liu J, Wu B, Wang X, Jiang Y, Zhu D
Int J Med Sci. 2022; 19(8):1216-1226.
PMID: 35928720
PMC: 9346389.
DOI: 10.7150/ijms.74137.
Zhu Y, Lu B, Wu J, Li S, Jia K
Vet Sci. 2022; 9(5).
PMID: 35622733
PMC: 9145538.
DOI: 10.3390/vetsci9050205.
Circular RNA expression pattern in cisplatin-resistant osteosarcoma cells.
Han J, Ye Z, Kong Q, Wu F, Wang G, Wang K
Transl Cancer Res. 2022; 9(1):262-270.
PMID: 35117180
PMC: 8798253.
DOI: 10.21037/tcr.2019.12.80.
Dissecting the Role of Circular RNAs in Sarcomas with Emphasis on Osteosarcomas.
Lakiotaki E, Kanakoglou D, Pampalou A, Karatrasoglou E, Piperi C, Korkolopoulou P
Biomedicines. 2021; 9(11).
PMID: 34829872
PMC: 8615931.
DOI: 10.3390/biomedicines9111642.
Exosomes as Efficient Nanocarriers in Osteosarcoma: Biological Functions and Potential Clinical Applications.
Yang L, Huang X, Guo H, Wang L, Yang W, Wu W
Front Cell Dev Biol. 2021; 9:737314.
PMID: 34712664
PMC: 8546119.
DOI: 10.3389/fcell.2021.737314.
Emerging important roles of circRNAs in human cancer and other diseases.
Huang Y, Zhang C, Xiong J, Ren H
Genes Dis. 2021; 8(4):412-423.
PMID: 34179306
PMC: 8209354.
DOI: 10.1016/j.gendis.2020.07.012.
Upregulated hsa_circRNA_100269 inhibits the growth and metastasis of gastric cancer through inactivating PI3K/Akt axis.
Wang Z, Liu C
PLoS One. 2021; 16(4):e0250603.
PMID: 33901239
PMC: 8075232.
DOI: 10.1371/journal.pone.0250603.
Emerging Roles and Potential Biological Value of CircRNA in Osteosarcoma.
Liu J, Yang L, Fu Q, Liu S
Front Oncol. 2020; 10:552236.
PMID: 33251132
PMC: 7673402.
DOI: 10.3389/fonc.2020.552236.
Silencing hsa_circRNA_0008035 exerted repressive function on osteosarcoma cell growth and migration by upregulating microRNA-375.
Gong G, Han Z, Wang W, Xu Q, Zhang J
Cell Cycle. 2020; 19(17):2139-2147.
PMID: 32779548
PMC: 7513843.
DOI: 10.1080/15384101.2020.1792636.
Circular RNA SFMBT2 Inhibits the Proliferation and Metastasis of Glioma Cells Through Mir-182-5p/Mtss1 Pathway.
Zhang S, Qin W, Yang S, Guan N, Sui X, Guo W
Technol Cancer Res Treat. 2020; 19:1533033820945799.
PMID: 32729377
PMC: 7394026.
DOI: 10.1177/1533033820945799.
Circular RNA hsa_circRNA_102209 promotes the growth and metastasis of colorectal cancer through miR-761-mediated Ras and Rab interactor 1 signaling.
Li C, Zhou H
Cancer Med. 2020; 9(18):6710-6725.
PMID: 32706154
PMC: 7520327.
DOI: 10.1002/cam4.3332.
Circular RNAs in Sepsis: Biogenesis, Function, and Clinical Significance.
Beltran-Garcia J, Osca-Verdegal R, Nacher-Sendra E, Pallardo F, Garcia-Gimenez J
Cells. 2020; 9(6).
PMID: 32630422
PMC: 7349763.
DOI: 10.3390/cells9061544.
Up-Regulation of Hsa_circ_0008792 Inhibits Osteosarcoma Cell Invasion and Migration and Promotes Apoptosis by Regulating Hsa-miR-711/ZFP1.
Chen L, Shan Y, Zhang H, Wang H, Chen Y
Onco Targets Ther. 2020; 13:2173-2181.
PMID: 32210583
PMC: 7073447.
DOI: 10.2147/OTT.S239256.
Circ-PAX2 promotes proliferation and metastasis by absorbing miR-186 in lung cancer cells.
Wang L, Xu C, Wang C, Gong W, Zhang K, Chen Q
Int J Clin Exp Pathol. 2020; 11(7):3793-3801.
PMID: 31949766
PMC: 6962841.
The clinicopathological significance of decreased miR-125b-5p in hepatocellular carcinoma: evidence based on RT-qPCR, microRNA-microarray, and microRNA-sequencing.
Guo Y, Dong H, Ma F, Huang J, Liang K, Peng J
Int J Clin Exp Pathol. 2020; 12(1):21-39.
PMID: 31933718
PMC: 6944034.
The Roles of Circular RNAs in Osteosarcoma.
Zhang Y, Li J, Wang Y, Jing J, Li J
Med Sci Monit. 2019; 25:6378-6382.
PMID: 31446435
PMC: 6724563.
DOI: 10.12659/MSM.915559.
Circ-SFMBT2 promotes the proliferation of gastric cancer cells through sponging miR-182-5p to enhance CREB1 expression.
Sun H, Xi P, Sun Z, Wang Q, Zhu B, Zhou J
Cancer Manag Res. 2018; 10:5725-5734.
PMID: 30510446
PMC: 6248399.
DOI: 10.2147/CMAR.S172592.